These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8471781)

  • 21. Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARalpha rearrangement in newly diagnosed AML. The Medical Research Council (MRC) Adult Leukaemia Working Party.
    Allford S; Grimwade D; Langabeer S; Duprez E; Saurin A; Chatters S; Walker H; Roberts P; Rogers J; Bain B; Patterson K; McKernan A; Freemont P; Solomon E; Burnett A; Goldstone A; Linch D
    Br J Haematol; 1999 Apr; 105(1):198-207. PubMed ID: 10233384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fallon leukaemia cluster findings, research plans announced.
    Furlow B
    Lancet Oncol; 2007 Jan; 8(1):9. PubMed ID: 17348115
    [No Abstract]   [Full Text] [Related]  

  • 23. The "typical" immunophenotype of acute promyelocytic leukemia (APL-M3): does it prove true for the M3-variant?
    Exner M; Thalhammer R; Kapiotis S; Mitterbauer G; Knöbl P; Haas OA; Jäger U; Schwarzinger I
    Cytometry; 2000 Apr; 42(2):106-9. PubMed ID: 10797447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of PG-M3 antibody in the diagnosis of acute promyelocytic leukaemia.
    Gupta SK; Sazawal S; Mahapatra M; Saxena R
    Eur J Clin Invest; 2010 Oct; 40(10):960-2. PubMed ID: 20701624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid.
    Autore F; Chiusolo P; Sorà F; Giammarco S; Laurenti L; Innocenti I; Metafuni E; Piccirillo N; Pagano L; Bacigalupo A; Leone G; Sica S
    Leuk Lymphoma; 2019 May; 60(5):1328-1330. PubMed ID: 30526180
    [No Abstract]   [Full Text] [Related]  

  • 26. Early mortality and survival improvements for adolescents and young adults with acute promyelocytic leukemia in California: an updated analysis.
    Abrahão R; Ribeiro RC; Malogolowkin MH; Wun T; Keegan THM
    Haematologica; 2022 Mar; 107(3):733-736. PubMed ID: 34320784
    [No Abstract]   [Full Text] [Related]  

  • 27. The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia.
    Santamaría C; Chillón MC; García-Sanz R; Balanzategui A; Sarasquete ME; Alcoceba M; Ramos F; Bernal T; Queizán JA; Peñarrubia MJ; Giraldo P; San Miguel JF; Gonzalez M
    Haematologica; 2008 Dec; 93(12):1797-805. PubMed ID: 18815192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunofluorescent analysis with the anti-PML monoclonal antibody PG-M3 for rapid and accurate genetic diagnosis of acute promyelocytic leukemia.
    Gomis F; Sanz J; Sempere A; Plumé G; Senent ML; Pérez ML; Cervera J; Moscardó F; Bolufer P; Barragán E; Martín G; Sanz MA
    Ann Hematol; 2004 Nov; 83(11):687-90. PubMed ID: 15278297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of international collaboration on the prognosis of childhood acute promyelocytic leukemia in Iraq.
    Testi AM; Al-Hadad SA; Al-Jadiry MF; Moleti ML; Mandelli F; Foà R
    Haematologica; 2006 Apr; 91(4):509-12. PubMed ID: 16533724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [M3 variant leukemia: clinical and diagnostic features].
    Lusis MK; Machado C; Brito AE; Tabak D; de Oliveira MS
    Rev Assoc Med Bras (1992); 1993; 39(4):224-8. PubMed ID: 8162087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of body mass index on incidence and prognosis of acute myeloid leukemia and acute promyelocytic leukemia: A meta-analysis.
    Li S; Chen L; Jin W; Ma X; Ma Y; Dong F; Zhu H; Li J; Wang K
    Sci Rep; 2017 Dec; 7(1):17998. PubMed ID: 29269861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Myeloid/natural killer cell acute leukemia resembling acute promyelocytic leukemia].
    Wang JN; Hou YQ; Zhang LB; Bao HY; Song M; Meng QQ; Fu XC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):830-4. PubMed ID: 23998568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between morphological and cytochemical heterogeneity of acute promyelocytic leukemia (APL) and its association with myelodysplasia.
    Varma N; Dash S; Sarode R
    Indian J Cancer; 1990 Sep; 27(3):165-71. PubMed ID: 2090569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3.
    Scott AA; Head DR; Kopecky KJ; Appelbaum FR; Theil KS; Grever MR; Chen IM; Whittaker MH; Griffith BB; Licht JD
    Blood; 1994 Jul; 84(1):244-55. PubMed ID: 7517211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. M3-variant of acute promyelocytic leukaemia. A case report in a Malay boy.
    Jazilah W; Ariffin W; Jackson N
    Med J Malaysia; 1995 Mar; 50(1):105-7. PubMed ID: 7752961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute Promyelocytic Leukemia: a Single Center Study from Southern Pakistan.
    Sultan S; Irfan SM; Ashar S
    Asian Pac J Cancer Prev; 2015; 16(17):7893-5. PubMed ID: 26625817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of patients with acute promyelocytic leukemia. The EORTC-LCG experience. EORTC Leukemia Cooperative Group.
    Willemze R; Suciu S; Mandelli F; de Witte T; Cadiou M; Castoldi GL; Liso V; Dardenne M; Solbu G; Zittoun R
    Leukemia; 1994; 8 Suppl 2():S48-55. PubMed ID: 7815837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolving characteristics and outcome of secondary acute promyelocytic leukemia (APL): A prospective analysis by the French-Belgian-Swiss APL group.
    Braun T; Cereja S; Chevret S; Raffoux E; Beaumont M; Detourmignies L; Pigneux A; Thomas X; Bordessoule D; Guerci A; Lamy T; Recher C; Poiré X; Tournilhac O; Spertini O; Chomienne C; Degos L; Dombret H; Adès L; Fenaux P;
    Cancer; 2015 Jul; 121(14):2393-9. PubMed ID: 25845577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Urgent states in hematology: acute promyelocytic leukemia--principles of diagnosis].
    Schwarz J; Kacírková P; Marková J; Mikulenková D; Marinov I; Ballingová I; Michalová K
    Vnitr Lek; 2008; 54(7-8):728-44. PubMed ID: 18780572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute promyelocytic leukemia toluidine blue subtype.
    Invernizzi R; Iannone AM; Bernuzzi S; D'Alessio A; Fiamenghi C; Fenoglio C; Rossi A; Bergamaschi G; Ascari E
    Leuk Lymphoma; 1995; 18 Suppl 1():57-60. PubMed ID: 7496356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.